| Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side R Prieto-Bermejo, M Romo-González, A Pérez-Fernández, C Ijurko, ... Journal of Experimental & Clinical Cancer Research 37, 1-18, 2018 | 118 | 2018 |
| Reactive oxygen species and metabolism in leukemia: a dangerous liaison M Romo-González, C Ijurko, Á Hernández-Hernández Frontiers in Immunology 13, 889875, 2022 | 24 | 2022 |
| SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia A Pérez-Fernández, G López-Ruano, R Prieto-Bermejo, C Ijurko, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 14 | 2019 |
| A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival C Ijurko, N González‐García, P Galindo‐Villardón, ... American Journal of Hematology 97 (4), 448-457, 2022 | 10 | 2022 |
| NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival C Ijurko, M Romo-González, C García-Calvo, JL Sardina, ... Free Radical Biology and Medicine 209, 18-28, 2023 | 4 | 2023 |
| NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia M Romo-González, C Ijurko, MT Alonso, MG de Cedrón, AR de Molina, ... Free Radical Biology and Medicine 198, 92-108, 2023 | 4 | 2023 |
| Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia C Ijurko, M Romo-González, R Prieto-Bermejo, M Díez-Campelo, ... Biomarker Research 12 (1), 128, 2024 | | 2024 |
| Delving into connection of LDH-B and mitochondria as an alternative AML treatment C Ijurko, M Romo-Gonzalez, F Sanchez-Guijo, A Hernandez-Hernandez 42nd Congress of SEBBM, 2019 | | 2019 |
| PF240 COMBINED INHIBITION OF SHP1 AND SHP2 WITH PHORBOL ESTERS AS A DIFFERENTIATION THERAPY AGAINST ACUTE MYELOID LEUKEMIA A Pérez‐Fernández, G López‐Ruano, R Prieto‐Bermejo, C Ijurko, ... HemaSphere 3, 72, 2019 | | 2019 |
